Neptune Wellness Solutions - NEPT Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Neptune Wellness Solutions in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" NEPT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NEPT, but not buy additional shares or sell existing shares.
View NEPT analyst ratings or view top-rated stocks.

2 Wall Street analysts have issued 12-month target prices for Neptune Wellness Solutions' stock. Their NEPT share price forecasts range from $26.25 to $26.25. On average, they predict the company's share price to reach $26.25 in the next year. This suggests a possible upside of 1,627.0% from the stock's current price.
View analysts price targets for NEPT or view top-rated stocks among Wall Street analysts.

Neptune Wellness Solutions' stock was trading at $14.35 at the beginning of 2022. Since then, NEPT stock has decreased by 89.4% and is now trading at $1.52.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, November 21st 2022.
View our NEPT earnings forecast.

Neptune Wellness Solutions Inc (NASDAQ:NEPT) issued its quarterly earnings data on Friday, July, 8th. The biotechnology company reported ($2.63) earnings per share (EPS) for the quarter. The biotechnology company had revenue of $11.53 million for the quarter. Neptune Wellness Solutions had a negative trailing twelve-month return on equity of 63.89% and a negative net margin of 110.52%.

Neptune Wellness Solutions's stock reverse split before market open on Monday, June 13th 2022. The 1-35 reverse split was announced on Monday, June 13th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, June 13th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Neptune Wellness Solutions investors own include Tilray (TLRY), Aurora Cannabis (ACB), Cronos Group (CRON), Cara Therapeutics (CARA), Innovative Industrial Properties (IIPR), Zynerba Pharmaceuticals (ZYNE), Amarin (AMRN) and NewAge (NBEV).

Neptune Wellness Solutions trades on the NASDAQ under the ticker symbol "NEPT."

Shares of NEPT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NEPT stock can currently be purchased for approximately $1.52.

Neptune Wellness Solutions (NASDAQ:NEPT) has a market capitalization of $12.72 million and generates $48.80 million in revenue each year. The biotechnology company earns $-74,970,000.00 in net income (profit) each year or ($12.2748) on an earnings per share basis.

Neptune Wellness Solutions' mailing address is 545 PROMENADE DU CENTROPOLIS SUITE 100, LAVAL A8, H7T 0A3. The official website for the company is www.neptunecorp.com. The biotechnology company can be reached via phone at 45-0687-2262, via email at m.paradis@neptunecorp.com, or via fax at 45-0687-2272.